Antimicrobial resistance (AMR) in bacterial pathogens is an ever-present threat to the effective treatment of infections
In 2014, almost all WHO regions surveyed reported an incidence of ≥50% Klebsiella pneumoniae and Escherichia coli that were resistant to third-generation cephalosporins.
In recent years, the rise in the number of infections caused by AMR pathogens—including pan-resistant, untreatable infections—is of huge concern.
There is a need to optimise the use of antibiotics through education and stewardship, Antibiotic stewardship can be defined as…
"A multifaceted and multidisciplinary approach involving, for example, infectious disease clinicians, pharmacists, microbiologists and hospital epidemiologists, to optimise clinical outcomes while minimising the unintended consequences of antibiotic use1–3"
What is the purpose of antibiotic stewardship programmes (ASPs)?
1. Combat AMR
2. Improve clinical outcomes
3. Minimise costs by improving antimicrobial use
To read the full report please click on the document below.